STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 29





                 Strelchenko Application 09/357,445, Paper I (specification), p. 10, L 29 - p. 11, 1. 14 (emphasis                                        
                 added). In stating that totipotent cells "arise from a precursor cell" Strelchenko uses the phrase                                       
                 "arises from" to include the conversion by reprogramming of a non-totipotent cell to a totipotent                                        
                 cell:                                                                                                                                    
                                  The term "arises from" as used herein refers to the conversion of one or more                                           
                                  cells into one or more other cells. For example, a non-totipotent precurso                                              
                                  cell can be converted into a totipotent cell by utilizing features of the                                               
                                  invention described hereafter. This conversion process can be referred to as                                            
                                  a reprogramming step.                                                                                                   
                 Strelchenko specification, p. 12,11. 10-16 (emphasis added).                                                                             
                          We find that Strelchenko referenced somatic cells in the specification as an example of non                                     
                 totipotent cells which may be reprogrammed to be totipotent for use in nuclear transfer. This usage                                      
                 is consistent with the ordinary meanings of both somatic and totipotent. We do not credit Dr.                                            
                 Forsberg's testimony because it is inconsistent with both the ordinary meaning and the usage of                                          
                 those terms in Strelchenko's specification, particularly with Strelchenko's identification of somatic                                    
                 cells precursor as non-totipotent cells which can be converted into totipotent cells for use in forming                                  
                 a cybrid.                                                                                                                                
                          Wehold that "totipotent"as used in Strelchenko's pre-critical date claims does not mean and                                     
                 does not cover "somatic." Strelchenko has not overcome the "heavy presumption" that a claim term                                         
                 takes on its ordinary meaning. Texas Digital Systems 308 F.3d at 1202,64 USPQ2d at 1818; CCS                                             
                 Fitness, 288 F.3d at 1366,62 USPQ2d at 1662; K-2 Colp. v. Salomon S.A., 191 F.3d 1356,1362-63,                                           
                 52 USPQ2d 1001, 1004 (Fed. Cir. 1999); Johnson Worldwide Assocs., Inc. v. Zebco Com., 175 F.3d                                           
                 985, 989,50 USPQ2d 1607,1610 (Fed. Cir. 1999); Specialty Composites v. Cabot Co1p., 845 F.2d                                             
                 981, 986, 6 USPQ2d 1601, 1604 (Fed. Cir. 1988). Thus, Strelchenko's precritical date claims and                                          
                 the Stice 577 claims are directed to substantially different subject matter.                                                             
                                                                        4.                                                                                
                          When the terms totipotent and somatic are properly construed, Stice's 577 claims and                                            
                 Strelchenko's precritical date claims are directed to fundamentally different processes. While one                                       
                 of the important goals ofthe subject matterofboth the Stice 577 claims and Strelchenko's precritical                                     
                 date claims was the same, i.e., the capability of using mature cells as the genetic starting material                                    

                                                                       -29-                                                                               







Page:  Previous  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  Next 

Last modified: November 3, 2007